Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current clinical trials testing the combination of immunotherapy with radiotherapy
Josephine Kang, Sandra Demaria, Silvia C. Formenti
Journal for ImmunoTherapy of Cancer (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 354

Showing 1-25 of 354 citing articles:

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille‐Box, Amandine Alard, Molykutty J. Aryankalayil, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 1442
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 313-322
Open Access | Times Cited: 1000
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan, et al.
The Lancet Oncology (2017) Vol. 18, Iss. 7, pp. 895-903
Open Access | Times Cited: 980
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Xueting Lang, Michael D. Green, Weimin Wang, et al.
Cancer Discovery (2019) Vol. 9, Iss. 12, pp. 1673-1685
Open Access | Times Cited: 796
DNA Damage and Repair Biomarkers of Immunotherapy Response
Kent W. Mouw, Michael S. Goldberg, Panagiotis A. Konstantinopoulos, et al.
Cancer Discovery (2017) Vol. 7, Iss. 7, pp. 675-693
Open Access | Times Cited: 581
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy, Megha Shettigar, Howard L. Kaufman
Nature reviews. Immunology (2018) Vol. 18, Iss. 8, pp. 498-513
Closed Access | Times Cited: 562
Improving immune–vascular crosstalk for cancer immunotherapy
Yuhui Huang, Betty Y.S. Kim, Charles K. F. Chan, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 3, pp. 195-203
Open Access | Times Cited: 441
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
María E. Rodríguez-Ruiz, Claire Vanpouille‐Box, Ignacio Melero, et al.
Trends in Immunology (2018) Vol. 39, Iss. 8, pp. 644-655
Open Access | Times Cited: 407
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 351
Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
Yifan Wang, Weiye Deng, Nan Li, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 332
Improving radiotherapy in cancer treatment: Promises and challenges
Helen H.W. Chen, Macus Tien Kuo
Oncotarget (2017) Vol. 8, Iss. 37, pp. 62742-62758
Open Access | Times Cited: 281
The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
Eric C. Ko, David Raben, Silvia C. Formenti
Clinical Cancer Research (2018) Vol. 24, Iss. 23, pp. 5792-5806
Closed Access | Times Cited: 239
Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy
Bagher Farhood, Keywan Mortezaee, Nasser Hashemi Goradel, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 5, pp. 5728-5740
Closed Access | Times Cited: 228
Radiotherapy and immune response: the systemic effects of a local treatment
Heloísa de Andrade Carvalho, Rosângela Correa Villar
Clinics (2018) Vol. 73, pp. e557s-e557s
Open Access | Times Cited: 205
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
Valerie Chew, Yun Hua Lee, Lu Pan, et al.
Gut (2018) Vol. 68, Iss. 2, pp. 335-346
Open Access | Times Cited: 190
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 188
Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells
Nils-Petter Rudqvist, Karsten A. Pilones, Claire Lhuillier, et al.
Cancer Immunology Research (2017) Vol. 6, Iss. 2, pp. 139-150
Open Access | Times Cited: 185
Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
Zachary S. Buchwald, Jacob Wynne, Tahseen H. Nasti, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 177
Immune checkpoint inhibitors: The linchpins of modern immunotherapy
Breelyn A. Wilky
Immunological Reviews (2019) Vol. 290, Iss. 1, pp. 6-23
Closed Access | Times Cited: 177
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
Partha S. Chowdhury, Kenji Chamoto, Tasuku Honjo
Journal of Internal Medicine (2017) Vol. 283, Iss. 2, pp. 110-120
Open Access | Times Cited: 176
Barriers to Radiation-Induced In Situ Tumor Vaccination
Erik Wennerberg, Claire Lhuillier, Claire Vanpouille‐Box, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 174
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou, M. Hipp, Ute Klinkhardt, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 171
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
Jun Gong, Thang Q. Le, Erminia Massarelli, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 164
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed I. Younes, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000537-e000537
Open Access | Times Cited: 157
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial
Shankar Siva, Mathias Bressel, Simon Wood, et al.
European Urology (2021) Vol. 81, Iss. 4, pp. 364-372
Closed Access | Times Cited: 104
Page 1 - Next Page

Scroll to top